Stocknear Logo Stocknear
/
Popular
Login

Revance Therapeutics Inc.

AI Score

XX

Unlock

3.65
0.00 (0.00%)
At close: Feb 05, 2025, 3:59 PM

Revance Therapeutics Income Statement

Financials in USD. Fiscal year is January - December.

Revenue peaked at - in undefined and hit its lowest at - in undefined. Over the past five years, it has declined by undefined%.

undefined

n/a
Fiscal Year FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 FY 2018 FY 2017 FY 2016
Period Ending Dec 31, 2023 Dec 31, 2022 Dec 31, 2021 Dec 31, 2020 Dec 31, 2019 Dec 31, 2018 Dec 31, 2017 Dec 31, 2016
234.04M 132.56M 77.8M 15.32M 413K 3.73M 262K 300K
152.16M 51.67M 23.41M 4.77M 102.86M 92.5M n/a n/a
81.88M 80.9M 54.39M 10.56M -102.45M -88.77M 262K 300K
-316.78M -272.17M -274.68M -273.16M -164.46M -142.63M -120.42M -88.22M
13.29M 4.89M 337K 4.32M 5.53M 4.02M 1.41M 1.17M
-323.69M -355.72M -281.31M -284.71M -159.43M -139.57M -120.59M -89.27M
-323.99M -356.42M -286.82M -282.09M -156.22M -142.57M -120.59M -89.27M
292.24M 223.93M 198.82M 151.85M 62.01M 53.86M 37.4M 29.07M
79.41M 101.29M 116.25M 125.8M 102.86M 92.5M 80.36M 50.38M
27.01M 27.85M 13.99M 6.08M -303K -773K -525K -535K
398.65M 353.07M 329.06M 283.72M 164.87M 146.36M 117.76M 79.46M
19.36M 16.47M 6.27M 15.15M n/a 44K 457K 1.08M
253.42M 183.1M 166.42M 2.1M n/a n/a n/a n/a
550.82M 404.73M 352.47M 288.49M 164.87M 146.36M 117.76M 79.46M
300K 700K 5.51M -2.62M -3.21M 3M -1.54M -898K
84.6M 72.71M 67.51M 58.01M 43.46M 36.17M 30.1M 28.11M
84.6M 72.71M 67.51M 58.01M 43.46M 36.17M 30.1M 28.11M
-3.83 -4.9 -4.25 -4.86 -3.59 -3.94 -4.01 -3.18
-3.83 -4.9 -4.25 -4.86 -3.59 -3.94 -4.01 -3.18
-290.64M -305.52M -255.18M -259.31M -156.52M -137.8M -118.66M -86.74M
-304.33M -339.25M -275.04M -269.56M -159.43M -139.52M -120.13M -88.19M
13.69M 33.73M 19.85M 10.25M 2.91M 1.73M 1.47M 1.45M

Create Price Alert on RVNC

Your price alert will notify you when the stock price is above 3.65.

Add to Watchlist